These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antilymphocyte globulin and renal transplantation.
    Author: Tagnon A.
    Journal: Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848.
    Abstract:
    ALG was used in 87 patients undergoing cadaveric renal transplantation. These patients were grouped into five different groups according to the batch of ALG which was given. In addition to receiving ALG prepared by immunization with cultured lymphoblasts our most recent patients (Group V) also received a shorter duration of ALG therapy in much higher doses. These variations may explain the differences in three month transplant survival which was seen with the various groups. (Group I 68% survival, Group II 80%, Group III86%, Group IV 47% and Group V 83%.) Is is suggested that the results are predictabe on the basis of skin graft prolongation in monkeys.
    [Abstract] [Full Text] [Related] [New Search]